SARS corona virus peptides recognized by antibodies in the sera of convalescent cases

DeGroot, 2003, How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past, Vaccine, 21, 4095, 10.1016/S0264-410X(03)00489-4 Kuo, 2000, Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier, J. Virol., 74, 1393, 10.1128/JVI.74.3.1393-1406.2000 Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145 Marra, 2003, The genome sequence of the SARS-associated coronavirus, Science, 300, 1399, 10.1126/science.1085953 Martina, 2003, SARS virus infection of cats and ferrets, Nature, 425, 815, 10.1038/425915a Rota, 2003, Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science, 300, 1394, 10.1126/science.1085952 Ruan, 2003, Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection, Lancet, 361, 1779, 10.1016/S0140-6736(03)13414-9 Snijder, 2003, Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage, J. Mol. Biol., 331, 991, 10.1016/S0022-2836(03)00865-9 Wentworth, 2001, Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation, J. Virol., 75, 9741, 10.1128/JVI.75.20.9741-9752.2001